(Q33379916)
Statements
A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer (English)
Bjørn H Grønberg
Roy M Bremnes
Ulf Aasebø
Paal Brunsvig
Tore Amundsen
Mari Wang
Stein Sundstrøm
Norwegian Lung Cancer Study Group